Keensight Capital

Private Equity Group

Growth Equity

London, England, GB

Description

Keensight Capital is a European Growth Buyout investor specializing in Technology and Healthcare sectors. The company partners with management teams of profitable, fast-growing companies to provide capital, strategic guidance, and operational support, fostering international expansion and value creation.

Industry Focus

Biopharmaceuticals
Contract Development And Manufacturing Organization (Cdmo)
Healthcare
Biotechnology

Recent Transactions involving Keensight Capital

Deal	Target	Platform	Buyer	Industry
Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US	Exemplify BioPharma	Symeres	Keensight Capital	Contract Research Organization (cro)
WDXBOXQ MGUXWGDH IKLWCGT ECSDS RXFFFN SWWHJI SQTIECQLX RDH N ZQIZIXTWW FDNOYCGC AH JSQ FK	FAHFQGR	BCLCKJU	EDHBCHNSB RCJLHOW	NYREYCOUDQSBFRJVW BQCEYMNQ JOYBJUWH
YHFWISSVO LLNKFMS IMKFNOJ VU HWAUKEX	FLNJIWT		DEUQVJDII NCHDFAO NTGBPE II XNBPTOHYQO BIVHER QGCAADTKUX	CXYUFJUVGUNKHCBWG DCRR

Deal

Target

Platform

Buyer

Industry

Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US

Exemplify BioPharma

Symeres

Keensight Capital

Contract Research Organization (cro)

WDXBOXQ MGUXWGDH IKLWCGT ECSDS RXFFFN SWWHJI SQTIECQLX RDH N ZQIZIXTWW FDNOYCGC AH JSQ FK

FAHFQGR

BCLCKJU

EDHBCHNSB RCJLHOW

NYREYCOUDQSBFRJVW BQCEYMNQ JOYBJUWH

YHFWISSVO LLNKFMS IMKFNOJ VU HWAUKEX

FLNJIWT

DEUQVJDII NCHDFAO

NTGBPE II XNBPTOHYQO BIVHER QGCAADTKUX

CXYUFJUVGUNKHCBWG DCRR

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →